217 related articles for article (PubMed ID: 38329887)
1. Current Small Molecule-Based Medicinal Chemistry Approaches for Neurodegeneration Therapeutics.
Sanghai N; Vuong B; Burak Berk A; Afridi MSK; Tranmer GK
ChemMedChem; 2024 May; 19(9):e202300705. PubMed ID: 38329887
[TBL] [Abstract][Full Text] [Related]
2. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine.
Jin S; Zhang L; Wang L
Biomed Pharmacother; 2023 Sep; 165():115215. PubMed ID: 37494786
[TBL] [Abstract][Full Text] [Related]
3. The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids.
Kooshki L; Zarneshan SN; Fakhri S; Moradi SZ; Echeverria J
Phytomedicine; 2023 Apr; 112():154686. PubMed ID: 36804755
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View.
Sanghai N; Tranmer GK
Cells; 2023 Sep; 12(18):. PubMed ID: 37759540
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders.
Gupta R; Advani D; Yadav D; Ambasta RK; Kumar P
Mol Neurobiol; 2023 Nov; 60(11):6476-6529. PubMed ID: 37458987
[TBL] [Abstract][Full Text] [Related]
6. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases.
Calzaferri F; Ruiz-Ruiz C; de Diego AMG; de Pascual R; Méndez-López I; Cano-Abad MF; Maneu V; de Los Ríos C; Gandía L; García AG
Med Res Rev; 2020 Nov; 40(6):2427-2465. PubMed ID: 32677086
[TBL] [Abstract][Full Text] [Related]
7. Multitarget therapeutic approaches for Alzheimer's and Parkinson's diseases: an opportunity or an illusion?
Matos MJ
Future Med Chem; 2021 Aug; 13(15):1301-1309. PubMed ID: 34137271
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach.
Trompetero A; Gordillo A; Del Pilar MC; Cristina VM; Bustos Cruz RH
Curr Pharm Des; 2018; 24(1):22-45. PubMed ID: 28847307
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
Han J; Du Z; Lim MH
Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
[TBL] [Abstract][Full Text] [Related]
10. Small molecule SUMOylation activators are novel neuroprotective agents.
Krajnak K; Dahl R
Bioorg Med Chem Lett; 2018 Feb; 28(3):405-409. PubMed ID: 29269215
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNAs: New Insights in Neurodegenerative Diseases.
Anilkumar AK; Vij P; Lopez S; Leslie SM; Doxtater K; Khan MM; Yallapu MM; Chauhan SC; Maestre GE; Tripathi MK
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396946
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries.
Tavassoly O; Sato T; Tavassoly I
Mol Pharmacol; 2020 Jul; 98(1):13-22. PubMed ID: 32350120
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids modulate AMPK/PGC-1α and interconnected pathways toward potential neuroprotective activities.
Gravandi MM; Fakhri S; Zarneshan SN; Yarmohammadi A; Khan H
Metab Brain Dis; 2021 Oct; 36(7):1501-1521. PubMed ID: 33988807
[TBL] [Abstract][Full Text] [Related]
14. Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases.
Fan HC; Chi CS; Cheng SN; Lee HF; Tsai JD; Lin SZ; Harn HJ
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712747
[TBL] [Abstract][Full Text] [Related]
15. Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents.
Viegas FPD; Gontijo VS; de Freitas Silva M; Ortiz CJC; Dos Reis Rosa Franco G; Ernesto JT; Damasio CM; Silva IMF; Campos TG; Viegas C
Curr Neuropharmacol; 2022; 20(7):1297-1328. PubMed ID: 34825873
[TBL] [Abstract][Full Text] [Related]
16. Association between CNS-active drugs and risk of Alzheimer's and age-related neurodegenerative diseases.
Cortes-Flores H; Torrandell-Haro G; Brinton RD
Front Psychiatry; 2024; 15():1358568. PubMed ID: 38487578
[TBL] [Abstract][Full Text] [Related]
17. Synopsis on Managment Strategies for Neurodegenerative Disorders: Challenges from Bench to Bedside in Successful Drug Discovery and Development.
Bhat SA; Kamal MA; Yarla NS; Ashraf GM
Curr Top Med Chem; 2017; 17(12):1371-1378. PubMed ID: 28017151
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases.
Bai X; Bian Z; Zhang M
Phytomedicine; 2023 Jan; 109():154582. PubMed ID: 36610130
[TBL] [Abstract][Full Text] [Related]
19. Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes.
Kumari S; Kamiya A; Karnik SS; Rohilla S; Dubey SK; Taliyan R
Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38856793
[TBL] [Abstract][Full Text] [Related]
20. Expanding therapeutic opportunities for neurodegenerative diseases: A perspective on the important role of phenotypic screening.
Swalley SE
Bioorg Med Chem; 2020 Feb; 28(3):115239. PubMed ID: 31889605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
